News & Articles
Bruker introduces new OmniScape workflows for de novo identification and proteoform characterization
Novel glycoproteomics de novo workflows with timsOmni™ and OmniScape™ enable confident proteoform characterization
View articleBruker introduces additions to ProteoScape software
ProteoScape (PS) software integrates the Kuiper machine learning-enhanced search engine, for immunopeptides, and TagGraph for neoepitope discovery
View articleBruker announces FDA clearance of Claims 7 and 8 for the MALDI Biotyper CA System
FDA clearance of MBT FAST™ Shuttle US IVD and MBT Compass HT CA software improves workflow efficiency and accelerates data processing and FDA approval of expanded reference library increases coverage to 549 validated microbial species
View articleBruker MALDI Biotyper sirius and sirius one systems awarded ACT label for environmental accountability
Recognition underscores Bruker’s commitment to sustainability and innovation in microbial detection
View articleBruker introduces new timsUltra AIP System at ASMS 2025
Breakthrough Athena Ion Processor (AIP) delivers up to 35% more peptide and 20% more protein identifications for highest sensitivity proteomics
View articleBruker launches revolutionary timsOmni mass spectrometer at ASMS 2025
Enabling functional proteoform sequencing and post-translational modification (PTM) identification and localization with unprecedented depth and speed
View articleNew proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025
Offering up to 50% improved peptide sensitivity, this technology further enhances robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows
View articlebiocrates life sciences ag becomes part of Bruker Group
This collaboration aims to expand metabolite and lipid analysis through the power of mass spectrometry
View articleBruker introduces novel timsMetabo mass spectrometer introduced at ASMS 2025
Game-changing sensitivity for TIMS-enabled small molecule analysis
View articleBruker announces majority acquisition of RECIPE, a leading provider of mass spectrometry-based diagnostic assay kits for therapeutic drug monitoring
Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays
View articleBruker to launch Beacon Discovery at AACR 2025, expanding access to live single-cell functional analysis
A compact benchtop optofluidic system with lower cost of ownership for broader research accessibility
View articleSpatial multiomics: Integrating imaging and LC/MS for enhanced biomolecular analysis
In this guest editorial, Pascal Steffen-Lockhauserbäumer, Global Product Manager for timsTOF at Bruker Daltonics explores how spatial multiomics combines imaging with LC/MS to revolutionize biomolecular analysis, enabling high-resolution insights into disease mechanisms, immune response, and tissue structure, with applications in diagnostics and personalized medicine
View article










